Sunil Patel, Director at LIGAND PHARMACEUTICALS INC (LGND), bought 5,000 shares at $10.74 ($54K) on 2011-08-10, disclosed to the SEC on 2011-08-11.
Open-market purchase of $54k LGND by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.72 | 260 | $3K | 5.2% |
| 2 | $10.73 | 700 | $8K | 14.0% |
| 3 | $10.74 | 100 | $1K | 2.0% |
| 4 | $10.74 | 384 | $4K | 7.7% |
| 5 | $10.75 | 100 | $1K | 2.0% |
| 6 | $10.75 | 3,456 |
| $37K |
| 69.2% |
| Total | $10.74 avg | 5,000 | $54K | 100% |
| Filing → |
| LGND | BUY | 2019-08-05 | $96K | — | Filing → |
| LGND | SELL | 2018-08-17 | $20.3M | — | Filing → |
| OMED | SELL | 2017-10-12 | $5K | — | Filing → |